Walgreens Boots Alliance Stock Price Target and Analyst Ratings (NASDAQ:WBA)

Analyst Price Target for WBA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$49.75

▼ -6.66% Downside Potential

This price target is based on 14 analysts offering 12 month price targets for Walgreens Boots Alliance in the last 3 months. The average price target is $49.75, with a high forecast of $60.00 and a low forecast of $33.00. The average price target represents a -6.66% upside from the last price of $53.30.

Hold

The current consensus among 14 contributing investment analysts is to hold stock in Walgreens Boots Alliance. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
3 buy ratings
14 hold ratings
2 sell ratings

Ratings as of

10/25/2019

0 strong buy ratings
2 buy ratings
14 hold ratings
1 sell ratings

Ratings as of

1/23/2020

0 strong buy ratings
0 buy ratings
13 hold ratings
1 sell ratings

Ratings as of

4/22/2020

0 strong buy ratings
0 buy ratings
14 hold ratings
1 sell ratings

Ratings as of

7/21/2020

0 strong buy ratings
0 buy ratings
14 hold ratings
2 sell ratings

Ratings as of

10/19/2020

0 strong buy ratings
2 buy ratings
13 hold ratings
2 sell ratings

Ratings as of

1/17/2021

0 strong buy ratings
2 buy ratings
13 hold ratings
2 sell ratings

Ratings as of

3/18/2021

0 strong buy ratings
2 buy ratings
10 hold ratings
2 sell ratings

Ratings as of

4/17/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
4/14/2021	Morgan Stanley	Boost Price Target	Equal Weight	$52.00 ➝ $60.00	Low	i
4/5/2021	Barclays	Boost Price Target	Equal Weight	$47.00 ➝ $55.00	High	i
4/1/2021	Truist Securities	Boost Price Target		$50.00 ➝ $58.00	Low	i
4/1/2021	Royal Bank of Canada	Boost Price Target		$44.00 ➝ $52.00	Low	i
4/1/2021	Truist Financial	Boost Price Target		$50.00 ➝ $58.00	Low	i
4/1/2021	Credit Suisse Group	Boost Price Target	Neutral	$46.00 ➝ $50.00	Low	i
3/30/2021	Morgan Stanley	Boost Price Target	Equal Weight	$40.00 ➝ $52.00	Low	i
3/29/2021	Cowen	Boost Price Target	Market Perform	$41.00 ➝ $53.00	Low	i
3/25/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$49.00 ➝ $55.00	Medium	i
1/27/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$44.00 ➝ $49.00	Medium	i
1/11/2021	Guggenheim	Upgrade	Neutral ➝ Buy	$55.00	High	i
1/11/2021	Mizuho	Boost Price Target	Positive ➝ Neutral	$37.00 ➝ $47.00	High	i
1/11/2021	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$41.00 ➝ $55.00	High	i
1/8/2021	Truist	Boost Price Target		$44.00 ➝ $48.00	Medium	i
1/8/2021	Barclays	Boost Price Target	Equal Weight	$40.00 ➝ $47.00	Low	i
1/8/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$41.00 ➝ $44.00	Low	i
1/7/2021	Credit Suisse Group	Initiated Coverage	Neutral	$42.00	Low	i Rating by A.J. Rice at Credit Suisse Group AG
1/5/2021	Truist Financial	Boost Price Target		$40.00 ➝ $44.00	N/A	i
10/16/2020	Citigroup	Lower Price Target	Neutral	$43.00 ➝ $40.00	Low	i
10/8/2020	Barclays	Lower Price Target	Equal Weight	$45.00 ➝ $40.00	Medium	i
10/7/2020	Bank of America	Reiterated Rating	Sell	$37.00	Medium	i Rating by Michael Cherny at Bank of America Co.
10/6/2020	The Goldman Sachs Group	Lower Price Target	Sell	$37.00 ➝ $33.00	Medium	i
9/11/2020	Mizuho	Lower Price Target	Neutral	$43.00 ➝ $37.00	Low	i
9/7/2020	Raymond James	Reiterated Rating	Hold		Medium	i
9/3/2020	Morgan Stanley	Lower Price Target	Equal Weight	$45.00 ➝ $40.00	Low	i
9/2/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$45.00 ➝ $38.00	Low	i
8/27/2020	Credit Suisse Group	Lower Price Target	Neutral	$45.00 ➝ $42.00	Medium	i Rating by A.J. Rice at Credit Suisse Group AG
7/21/2020	Mizuho	Lower Price Target	Neutral	$48.00 ➝ $43.00	Medium	i
7/10/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$43.00 ➝ $38.00	Medium	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
7/10/2020	Bank of America	Lower Price Target	Underperform	$43.00 ➝ $40.00	Medium	i
7/10/2020	SunTrust Banks	Lower Price Target	Hold	$42.00 ➝ $40.00	High	i
7/10/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$48.00 ➝ $45.00	High	i
7/10/2020	Credit Suisse Group	Initiated Coverage	Hold	$50.00 ➝ $45.00	High	i
7/10/2020	Barclays	Lower Price Target	Equal Weight	$50.00 ➝ $45.00	High	i
7/10/2020	Citigroup	Lower Price Target	Neutral	$48.00 ➝ $43.00	High	i
7/2/2020	Morgan Stanley	Lower Price Target	Equal Weight	$49.00 ➝ $45.00	High	i
6/4/2020	Mizuho	Lower Price Target	Outperform ➝ Neutral	$53.00 ➝ $48.00	Medium	i Rating by Ann Hynes at Mizuho
5/19/2020	Cowen	Lower Price Target	Neutral ➝ Market Perform	$54.00 ➝ $48.00	Low	i
4/6/2020	UBS Group	Upgrade	Sell ➝ Neutral	$49.00 ➝ $44.00	High	i
4/3/2020	JPMorgan Chase & Co.	Lower Price Target	Neutral	$62.00 ➝ $56.00	Medium	i
4/3/2020	SunTrust Banks	Lower Price Target	Positive ➝ Hold	$58.00 ➝ $42.00	Low	i
4/3/2020	Credit Suisse Group	Lower Price Target	Neutral	$60.00 ➝ $50.00	Low	i
4/3/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$57.00 ➝ $48.00	Medium	i
4/3/2020	Barclays	Lower Price Target	Equal Weight	$60.00 ➝ $50.00	Medium	i
4/3/2020	Deutsche Bank Aktiengesellschaft	Upgrade	Sell ➝ Hold	$51.00 ➝ $43.00	Low	i
4/2/2020	Wells Fargo & Company	Reiterated Rating	Hold		Low	i Rating by Peter Costa at Wells Fargo & Company
4/1/2020	Credit Suisse Group	Lower Price Target	Neutral	$60.00 ➝ $50.00	High	i
2/10/2020	Cowen	Lower Price Target	Market Perform	$60.00 ➝ $54.00	Low	i
1/9/2020	Mizuho	Reiterated Rating	Hold	$59.00	Low	i Rating by Ann Hynes at Mizuho
1/2/2020	Bank of America	Reiterated Rating	Sell	$50.00	Low	i Rating by Michael Cherny at Bank of America Co.
12/18/2019	SunTrust Banks	Boost Price Target	Hold	$58.00 ➝ $60.00	Low	i
12/11/2019	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight		Low	i
12/9/2019	Wells Fargo & Company	Reiterated Rating	Outperform ➝ Market Perform	$65.00 ➝ $61.00	Low	i
10/30/2019	Pivotal Research	Lower Price Target	Hold	$60.00 ➝ $55.00	Low	i
10/23/2019	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$73.00 ➝ $63.00	Low	i
10/3/2019	Bank of America	Lower Price Target	Underperform	$51.00 ➝ $50.00	Low	i
9/27/2019	Royal Bank of Canada	Downgrade	Hold	$59.00	Medium	i Rating by Anton Hie at Royal Bank of Canada
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Sell		Low	i
9/9/2019	Cleveland Research	Reiterated Rating	Hold		High	i Rating by Rob Eich at Cleveland Research
8/23/2019	Morgan Stanley	Lower Price Target	Equal Weight	$61.00 ➝ $58.00	High	i Rating by Ricky Goldwasser at Morgan Stanley
6/28/2019	JPMorgan Chase & Co.	Lower Price Target	Overweight	$74.00 ➝ $73.00	Low	i
6/3/2019	Bank of America	Lower Price Target	Underperform	$53.00 ➝ $51.00	Medium	i
5/14/2019	Morgan Stanley	Set Price Target	Hold	$61.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
4/18/2019	Guggenheim	Initiated Coverage	Neutral ➝ Neutral	$59.00	Low	i
4/3/2019	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$67.00 ➝ $61.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
4/3/2019	SunTrust Banks	Boost Price Target	Hold	$58.00	Low	i
4/3/2019	Citigroup	Lower Price Target	Neutral ➝ Neutral	$76.00 ➝ $60.00	Low	i
4/3/2019	UBS Group	Lower Price Target	Sell ➝ Sell	$60.00 ➝ $49.00	Low	i
4/3/2019	Pivotal Research	Lower Price Target	Hold	$70.00 ➝ $60.00	High	i
4/3/2019	Wells Fargo & Company	Lower Price Target	Outperform	$75.00 ➝ $65.00	High	i
4/3/2019	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$78.00 ➝ $60.00	High	i
4/3/2019	Loop Capital	Downgrade	Buy ➝ Hold	$77.00 ➝ $60.00	High	i Rating by Andrew Wolf at Loop Capital
3/31/2019	Cowen	Reiterated Rating	Hold	$66.00	Low	i
3/28/2019	Mizuho	Set Price Target	Hold	$67.00	Low	i Rating by Ann Hynes at Mizuho
3/27/2019	Loop Capital	Lower Price Target	Buy	$77.00	Low	i Rating by Andrew Wolf at Loop Capital
3/8/2019	Bank of America	Reiterated Rating	Underperform ➝ Underperform	$69.00 ➝ $62.00	Low	i
3/5/2019	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$77.00 ➝ $67.00	High	i Rating by Ricky Goldwasser at Morgan Stanley
3/4/2019	UBS Group	Lower Price Target	Sell ➝ Sell	$70.00 ➝ $65.00	High	i
3/1/2019	Robert W. Baird	Lower Price Target	Neutral ➝ Neutral	$70.00 ➝ $67.00	Medium	i Rating by Eric Coldwell at Robert W. Baird
1/23/2019	Loop Capital	Set Price Target	Buy	$82.00	Low	i Rating by Andrew Wolf at Loop Capital
1/17/2019	UBS Group	Initiated Coverage	Sell ➝ Sell	$70.00	Low	i
12/21/2018	Robert W. Baird	Lower Price Target	Neutral ➝ Neutral	$71.00 ➝ $70.00	High	i
12/20/2018	Needham & Company LLC	Upgrade	Buy	$94.00	Low	i Rating by Kevin Caliendo at Needham & Company LLC
12/20/2018	Loop Capital	Set Price Target	Buy	$82.00	High	i Rating by Andrew Wolf at Loop Capital
12/19/2018	Wolfe Research	Reiterated Rating	Peer Perform ➝ Peer Perform		High	i
12/14/2018	The Goldman Sachs Group	Downgrade	Neutral ➝ Sell		High	i
12/3/2018	Morgan Stanley	Boost Price Target	Equal Weight ➝ Equal Weight	$55.00 ➝ $77.00	Medium	i
10/15/2018	Pivotal Research	Boost Price Target	Hold ➝ Hold	$60.00 ➝ $72.00	Medium	i Rating by Ajay Jain at Pivotal Research
10/12/2018	Barclays	Boost Price Target	Equal Weight	$77.00 ➝ $80.00	Medium	i
10/12/2018	Robert W. Baird	Boost Price Target	Neutral	$69.00 ➝ $71.00	Medium	i
10/12/2018	Citigroup	Boost Price Target	Neutral	$69.00 ➝ $76.00	Medium	i
10/12/2018	SunTrust Banks	Boost Price Target	Hold	$75.00	High	i
10/12/2018	Loop Capital	Boost Price Target	Buy	$80.00 ➝ $82.00	High	i Rating by Andrew Wolf at Loop Capital
10/8/2018	JPMorgan Chase & Co.	Boost Price Target	Overweight ➝ Overweight	$83.00 ➝ $91.00	High	i
10/8/2018	Royal Bank of Canada	Set Price Target	Outperform ➝ Outperform	$68.00 ➝ $82.00	High	i
9/11/2018	Robert W. Baird	Boost Price Target	Neutral ➝ Neutral	$64.00 ➝ $69.00	Low	i
7/23/2018	Cowen	Downgrade	Outperform ➝ Market Perform	$104.00	Low	i
7/9/2018	Citigroup	Downgrade	Buy ➝ Neutral	$69.00	Low	i
7/2/2018	Pivotal Research	Lower Price Target	Hold	$70.00 ➝ $60.00	Low	i Rating by Ajay Jain at Pivotal Research
7/2/2018	Mizuho	Downgrade	Buy ➝ Neutral	$64.00	Medium	i Rating by Ann Hynes at Mizuho
6/29/2018	Royal Bank of Canada	Reiterated Rating	Outperform		Low	i Rating by George Hill at Royal Bank of Canada
6/29/2018	Loop Capital	Boost Price Target	Buy	$80.00	Low	i Rating by Andrew Wolf at Loop Capital
6/29/2018	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$85.00 ➝ $65.00	Low	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
6/29/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$80.00	Low	i
6/28/2018	Bank of America	Downgrade	Neutral ➝ Underperform	$73.00 ➝ $60.00	High	i Rating by Michael Cherny at Bank of America Co.
5/29/2018	Mizuho	Set Price Target	Buy	$77.00	Medium	i Rating by Ann Hynes at Mizuho
5/23/2018	SVB Leerink	Lower Price Target	Market Perform ➝ Market Perform	$75.00 ➝ $70.00	Low	i
4/3/2018	Jefferies Financial Group	Set Price Target	Buy	$85.00	Low	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
4/2/2018	Scotiabank	Lower Price Target	Outperform	$93.00 ➝ $91.00	Low	i
3/29/2018	Pivotal Research	Set Price Target	Hold	$70.00	Low	i Rating by Ajay Jain at Pivotal Research
3/28/2018	Royal Bank of Canada	Set Price Target	Buy	$88.00	High	i Rating by George Hill at Royal Bank of Canada
3/23/2018	Pivotal Research	Lower Price Target	Hold	$73.00 ➝ $69.00	High	i Rating by Ajay Jain at Pivotal Research
3/8/2018	Barclays	Initiated Coverage	Equal Weight ➝ Equal Weight	$76.00	Low	i
2/27/2018	Bank of America	Initiated Coverage	Neutral ➝ Neutral	$76.00	High	i
2/16/2018	Royal Bank of Canada	Set Price Target	Buy	$94.00	Low	i
2/13/2018	Loop Capital	Set Price Target	Buy	$90.00	Medium	i Rating by Andrew Wolf at Loop Capital
1/24/2018	Mizuho	Set Price Target	Buy	$87.00	Low	i Rating by Ann Hynes at Mizuho
1/10/2018	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$86.00 ➝ $88.00	Low	i
1/5/2018	Pivotal Research	Set Price Target	Hold	$73.00	High	i Rating by Ajay Jain at Pivotal Research
1/4/2018	Robert W. Baird	Reiterated Rating	Buy	$82.00	Medium	i
1/4/2018	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$80.00	High	i
1/3/2018	Loop Capital	Set Price Target	Buy	$90.00	High	i Rating by Andrew Wolf at Loop Capital
12/21/2017	SunTrust Banks	Set Price Target	Hold	$80.00	Low	i Rating by David S Macdonald at SunTrust Banks, Inc.
12/4/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$78.00	Low	i
11/22/2017	Needham & Company LLC	Lower Price Target	Buy	$86.00	N/A	i
11/2/2017	Citigroup	Lower Price Target	Buy	$95.00 ➝ $81.00	N/A	i
11/1/2017	SVB Leerink	Downgrade	Outperform ➝ Market Perform		N/A	i Rating by D. Larsen at SVB Leerink LLC
10/29/2017	Jefferies Financial Group	Set Price Target	Buy	$93.00	N/A	i
10/26/2017	Loop Capital	Set Price Target	Buy	$95.00 ➝ $90.00	N/A	i
10/25/2017	Royal Bank of Canada	Reiterated Rating	Buy	$88.00	N/A	i
10/24/2017	Mizuho	Set Price Target	Buy	$94.00	N/A	i
10/24/2017	Pivotal Research	Lower Price Target	Hold ➝ Hold	$85.00 ➝ $73.00	N/A	i
10/19/2017	Robert W. Baird	Reiterated Rating	Outperform	$90.00 ➝ $80.00	N/A	i
10/15/2017	SunTrust Banks	Set Price Target	Hold	$72.00	N/A	i
10/12/2017	Needham & Company LLC	Reiterated Rating	Buy	$94.00	N/A	i
10/6/2017	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$95.00 ➝ $85.00	N/A	i
10/2/2017	Jefferies Financial Group	Reiterated Rating	Buy	$95.00	Low	i
9/27/2017	Raymond James	Reiterated Rating	Outperform ➝ Market Perform		Low	i
9/20/2017	Jefferies Financial Group	Reiterated Rating	Buy	$95.00	Low	i
9/19/2017	Royal Bank of Canada	Initiated Coverage	Outperform ➝ Outperform	$96.00	Medium	i
9/16/2017	Needham & Company LLC	Reiterated Rating	Buy	$94.00	Low	i
9/10/2017	Needham & Company LLC	Reiterated Rating	Buy	$94.00	Low	i
9/7/2017	Jefferies Financial Group	Reiterated Rating	Buy	$95.00	Low	i
8/24/2017	Loop Capital	Initiated Coverage	Buy ➝ Buy	$95.00	Low	i
8/23/2017	UBS Group	Reiterated Rating	Buy	$97.00 ➝ $96.00	Low	i
7/17/2017	Needham & Company LLC	Set Price Target	Buy	$94.00	Low	i
7/13/2017	Credit Suisse Group	Reiterated Rating	Buy	$97.00	Low	i
7/7/2017	SVB Leerink	Set Price Target	Buy	$90.00 ➝ $86.00	Low	i
7/3/2017	Citigroup	Reiterated Rating	Buy		Low	i
7/3/2017	Guggenheim	Reiterated Rating	Buy		Low	i
7/3/2017	Morgan Stanley	Reiterated Rating	Overweight	$95.00	Low	i
7/2/2017	Pivotal Research	Set Price Target	Hold	$85.00	Low	i
6/30/2017	Needham & Company LLC	Upgrade	Hold ➝ Buy	$94.00	Low	i
6/28/2017	The Goldman Sachs Group	Reiterated Rating	Neutral	$89.00 ➝ $77.00	Low	i
6/27/2017	Needham & Company LLC	Initiated Coverage	Hold ➝ Hold		Low	i
5/31/2017	Jefferies Financial Group	Lower Price Target	Buy	$95.00 ➝ $80.00	Medium	i
4/11/2017	SVB Leerink	Set Price Target	Buy	$90.00	Low	i
4/6/2017	Jefferies Financial Group	Reiterated Rating	Buy	$95.00	Low	i
4/6/2017	Guggenheim	Reiterated Rating	Buy	$100.00	Low	i
4/4/2017	Pivotal Research	Initiated Coverage	Hold ➝ Hold	$85.00	Medium	i
4/1/2017	Barclays	Set Price Target	Hold	$79.00	Low	i
3/31/2017	Jefferies Financial Group	Reiterated Rating	Buy	$95.00	Low	i
3/27/2017	Robert W. Baird	Reiterated Rating	Outperform	$96.00	Low	i
3/22/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$92.00	Low	i
2/6/2017	Atlantic Securities	Upgrade	Neutral ➝ Overweight	$95.00	N/A	i
1/31/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$92.00	N/A	i
1/31/2017	Evercore ISI	Reiterated Rating	Buy	$93.00	N/A	i
1/31/2017	Wells Fargo & Company	Reiterated Rating	Outperform		N/A	i
1/24/2017	Robert W. Baird	Reiterated Rating	Outperform		N/A	i
1/23/2017	Jefferies Financial Group	Reiterated Rating	Buy	$95.00	N/A	i
1/21/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$92.00	N/A	i
1/8/2017	SVB Leerink	Set Price Target	Buy	$90.00	N/A	i
1/6/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$88.00	N/A	i
1/6/2017	Jefferies Financial Group	Reiterated Rating	Buy	$95.00	N/A	i
12/21/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A	i
11/10/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$88.00	N/A	i
11/8/2016	SVB Leerink	Set Price Target	Buy	$90.00	N/A	i
11/8/2016	Jefferies Financial Group	Set Price Target	Buy	$95.00	N/A	i
10/31/2016	Wells Fargo & Company	Initiated Coverage	Outperform		N/A	i
10/23/2016	Jefferies Financial Group	Set Price Target	Buy	$95.00	N/A	i
10/21/2016	Barclays	Set Price Target	Hold	$79.00	N/A	i
10/21/2016	Credit Suisse Group	Reiterated Rating	Outperform	$95.00	N/A	i
10/20/2016	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$94.00 ➝ $88.00	N/A	i
10/17/2016	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$87.00 ➝ $95.00	N/A	i
10/5/2016	UBS Group	Initiated Coverage	Buy	$80.51 ➝ $94.00	N/A	i
10/4/2016	Robert W. Baird	Reiterated Rating	Outperform	$95.00	N/A	i
10/3/2016	Credit Suisse Group	Reiterated Rating	Buy	$95.00	N/A	i
9/28/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$94.00	N/A	i
9/19/2016	SVB Leerink	Reiterated Rating	Outperform	$95.00	N/A	i
9/10/2016	Robert W. Baird	Reiterated Rating	Outperform	$95.00	N/A	i
9/9/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$94.00	N/A	i
9/1/2016	Credit Suisse Group	Reiterated Rating	Outperform ➝ Outperform	$80.71 ➝ $95.00	N/A	i
8/30/2016	Bank of America	Reiterated Rating	Buy	$94.00	N/A	i
8/30/2016	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$93.00 ➝ $94.00	N/A	i
8/30/2016	SVB Leerink	Reiterated Rating	Outperform		N/A	i
7/22/2016	Keefe, Bruyette & Woods	Reiterated Rating	Market Perform ➝ Underperform		N/A	i
7/18/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy		N/A	i
7/18/2016	Credit Suisse Group	Reiterated Rating	Buy	$95.00 ➝ $82.51	N/A	i
7/7/2016	JPMorgan Chase & Co.	Reiterated Rating	Buy		N/A	i
7/7/2016	Barclays	Boost Price Target	Equal Weight	$76.00 ➝ $79.00	N/A	i
7/7/2016	Jefferies Financial Group	Reiterated Rating	Hold ➝ Neutral		N/A	i
7/7/2016	(FBRC)	Lower Price Target	Market Perform	$90.00 ➝ $85.00	N/A	i
7/7/2016	Evercore ISI	Reiterated Rating	Buy	$93.00	N/A	i
6/27/2016	Robert W. Baird	Reiterated Rating	Outperform	$98.00	N/A	i
6/13/2016	Bank of America	Reiterated Rating	Buy		N/A	i
6/10/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy		N/A	i
6/7/2016	Bank of America	Reiterated Rating	Buy	$94.00 ➝ $78.66	N/A	i
4/19/2016	Jefferies Financial Group	Reiterated Rating	Hold		N/A	i

(Data available from 4/18/2016 forward)

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides specialty pharmacy services and mail services. As of August 31, 2020, this segment operated 9,021 retail stores under the Walgreens and Duane Reade brands in the United States; and six specialty pharmacies. The Retail Pharmacy International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,428 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 550 optical practices, including 165 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Today's Range

Now: $53.30

$53.25

$54.26

50 Day Range

MA: $52.07

$46.86

$56.80

52 Week Range

Now: $53.30

$33.36

$57.05

Volume

4,729,421 shs

Average Volume

6,494,007 shs

Market Capitalization

$46.07 billion

P/E Ratio

106.60

Dividend Yield

3.43%

Beta

0.44

Frequently Asked Questions

What sell-side analysts currently cover shares of Walgreens Boots Alliance?

The following equities research analysts have issued research reports on Walgreens Boots Alliance in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Guggenheim, Mizuho, Morgan Stanley, Raymond James, Robert W. Baird, Royal Bank of Canada, SunTrust Banks, Inc., The Goldman Sachs Group, Inc., TheStreet, Truist, Truist Financial Co., Truist Securities, and Zacks Investment Research.
View the latest analyst ratings for WBA.

What is the current price target for Walgreens Boots Alliance?

16 Wall Street analysts have set twelve-month price targets for Walgreens Boots Alliance in the last year. Their average twelve-month price target is $49.75, suggesting a possible downside of 6.7%. Morgan Stanley has the highest price target set, predicting WBA will reach $60.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $33.00 for Walgreens Boots Alliance in the next year.
View the latest price targets for WBA.

What is the current consensus analyst rating for Walgreens Boots Alliance?

Walgreens Boots Alliance currently has 2 sell ratings, 10 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in WBA, but not buy more shares or sell existing shares.
View the latest ratings for WBA.

What other companies compete with Walgreens Boots Alliance?

Other companies that are similar to Walgreens Boots Alliance include CVS Health, Covetrus, 111, Rite Aid, PetMed Express, Progressive Care, China Jo-Jo Drugstores, HealthWarehouse.com, Dragon Jade International, Dougherty's Pharmacy, China Dasheng Biotechnology and Health Sciences Group.

How do I contact Walgreens Boots Alliance's investor relations team?

Walgreens Boots Alliance's physical mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator's listed phone number is 847-315-2500 and its investor relations email address is [email protected] The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com.

NASDAQ:WBA - Walgreens Boots Alliance Stock Price Target and Predictions

Analyst Price Target for WBA

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Walgreens Boots Alliance?

What is the current price target for Walgreens Boots Alliance?

What is the current consensus analyst rating for Walgreens Boots Alliance?

What other companies compete with Walgreens Boots Alliance?

How do I contact Walgreens Boots Alliance's investor relations team?